A multicenter phase II trial of tumor treating fields plus chemotherapy for first-line treatment of gastric adenocarcinoma

被引：0
|
作者：
Li, Jin
Yeo, Winnie
Lam, Ka-On
机构：
[1] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Med Oncol,Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS474
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor Treating Fields (TTFields) therapy plus XELOX chemotherapy for front line treatment of advanced unresectable gastroesophageal junction adenocarcinoma (GEJC) or gastric adenocarcinoma (GC): A multicenter phase II trial
    Li, J.
    Cang, S.
    Ling, Y.
    Lam, K. O.
    Chen, Y.
    Xu, Y.
    Yang, Y.
    Lavy-Shahaf, G.
    Zhang, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1455 - S1455
  • [2] Tumor Treating Fields plus chemotherapy for first-line treatment of malignant pleural mesothelioma: Final Results of the STELLAR Trial
    Ceresoli, G.
    Aerts, J.
    Madrzak, J.
    Dziadziuszko, R.
    Ramlau, R.
    Cedres, S.
    Hiddinga, B.
    Van Meerbeeck, J. P.
    Mencoboni, M.
    Planchard, D.
    Chella, A.
    Krzakowski, M.
    Crino, L.
    Grosso, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 230 - 231
  • [3] The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma
    Gong, Jifang
    Hu, Bing
    Zhang, Xiaotian
    Zhang, Fengchun
    Zhang, Jun
    Xu, Nong e
    Fan, Qingxia
    Bai, Yuxian
    Jiao, Shunchang
    Wang, Jinwan
    Bai, Chunmei
    Zheng, Leizhen
    Shi, Yingqiang
    Liu, Yunpeng
    Liang, Jun
    Hu, Guoqing
    Cheng, Ying
    Xu, Ruihua
    Bai, Yu
    Shen, Lin
    ONCOLOGIST, 2014, 19 (02): : 173 - 174
  • [4] Tumor treating fields plus chemotherapy for first-line malignant pleural mesothelioma (MPM): Radiological responses in the STELLAR trial
    Grosso, F.
    Ceresoli, G. L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer
    Yang, Tingsong
    Shen, Xiaojun
    Tang, Xiaojun
    Wei, Guo
    Zhang, Hao
    Du, Chenghui
    Xue, Xuchao
    Ma, Liye
    Nie, Mingming
    Bi, Jianwei
    TUMORI, 2011, 97 (04) : 466 - 472
  • [6] A Phase II, Randomized Trial of Trilaciclib Plus Chemotherapy and Tislelizumab as First-Line Treatment for Advanced SqNSCLC
    Wang, Y.
    Shi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S396 - S396
  • [7] A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    Yang Lin
    Song Yan
    Zhou Ai-ping
    Qin Qiong
    Chi Yihebali
    Huang Jing
    Wang Jin-wan
    CHINESE MEDICAL JOURNAL, 2013, 126 (18) : 3470 - 3474
  • [8] Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
    Hai-Qiang Mai
    Qiu-Yan Chen
    Dongping Chen
    Chaosu Hu
    Kunyu Yang
    Jiyu Wen
    Jingao Li
    Ying-Rui Shi
    Feng Jin
    Ruilian Xu
    Jianji Pan
    Shenhong Qu
    Ping Li
    Chunhong Hu
    Yi-Chun Liu
    Yi Jiang
    Xia He
    Hung-Ming Wang
    Wan-Teck Lim
    Wangjun Liao
    Xiaohui He
    Xiaozhong Chen
    Zhigang Liu
    Xianglin Yuan
    Qi Li
    Xiaoyan Lin
    Shanghua Jing
    Yanju Chen
    Yin Lu
    Ching-Yun Hsieh
    Muh-Hwa Yang
    Chia-Jui Yen
    Jens Samol
    Hui Feng
    Sheng Yao
    Patricia Keegan
    Rui-Hua Xu
    Nature Medicine, 2021, 27 : 1536 - 1543
  • [9] Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
    Mai, Hai-Qiang
    Chen, Qiu-Yan
    Chen, Dongping
    Hu, Chaosu
    Yang, Kunyu
    Wen, Jiyu
    Li, Jingao
    Shi, Ying-Rui
    Jin, Feng
    Xu, Ruilian
    Pan, Jianji
    Qu, Shenhong
    Li, Ping
    Hu, Chunhong
    Liu, Yi-Chun
    Jiang, Yi
    He, Xia
    Wang, Hung-Ming
    Lim, Wan-Teck
    Liao, Wangjun
    He, Xiaohui
    Chen, Xiaozhong
    Liu, Zhigang
    Yuan, Xianglin
    Li, Qi
    Lin, Xiaoyan
    Jing, Shanghua
    Chen, Yanju
    Lu, Yin
    Hsieh, Ching-Yun
    Yang, Muh-Hwa
    Yen, Chia-Jui
    Samol, Jens
    Feng, Hui
    Yao, Sheng
    Keegan, Patricia
    Xu, Rui-Hua
    NATURE MEDICINE, 2021, 27 (09) : 1536 - +
  • [10] First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
    Hegewisch-Becker, Susanna
    Mendez, Guillermo
    Chao, Joseph
    Nemecek, Radim
    Feeney, Kynan
    Van Cutsem, Eric
    Al-Batran, Salah-Eddin
    Mansoor, Wasat
    Maisey, Nicholas
    Pazo Cid, Roberto
    Burge, Matthew
    Perez-Callejo, David
    Hipkin, R. William
    Mukherjee, Sourav
    Lei, Ming
    Tang, Hao
    Suryawanshi, Satyendra
    Kelly, Ronan J.
    Tebbutt, Niall C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17) : 2080 - 2093
12345